Asthma and Chronic Obstructive Pulmonary Disease (COPD) are chronic respiratory diseases affecting millions of people worldwide. In recent years, with developments in the field of regenerative medicine, exosome therapy and nasal exosome applications have taken their place among the innovative approaches being researched for respiratory system diseases. In this article, we discuss the potential use of nasal exosomes in asthma and COPD, along with the current scientific status.

What is an Exosome?

Exosomes are microscopic vesicles naturally secreted by cells, carrying growth factors, proteins, lipids, and genetic material. In particular, exosomes derived from mesenchymal stem cells can support intercellular communication and play a role in tissue repair and the regulation of immune responses.

What is a Nasal Exosome?

Nasal exosome refers to the administration of exosomes through the nose. This method aims for local access to the upper respiratory tract. The procedure is non-invasive and can be performed in a short amount of time.

The Potential Role of Exosomes in Asthma

Asthma is characterized by chronic inflammation in the airways. In experimental and early-stage research, it has been shown that exosomes may:

• Contribute to the regulation of the inflammatory response

• Support tissue repair processes

• Help reduce oxidative stress

• Support the healing of the airway epithelium

Nasal application aims for direct access to the upper airways. However, large-scale clinical trials for this specific use are still limited.

The Use of Exosomes in COPD

COPD is characterized by chronic inflammation and lung tissue damage caused by smoking and other harmful particles. Research suggests that exosomes may:

• Support the repair processes of lung tissue

• Contribute to reducing inflammation

• Help limit the development of fibrosis (scarring)

• Support cellular regeneration

However, a significant portion of these findings has been obtained from laboratory and early-phase clinical studies.

Possible Advantages of Nasal Exosomes

• Does not require a surgical procedure

• Short application time

• Offers the possibility of local application to the upper respiratory tract

• Allows the patient to quickly return to their daily life

Who Can Be Evaluated for This?

Following a physician’s evaluation, suitability can be assessed on an individual basis for patients with:

• Asthma

• COPD

• Chronic sinusitis

• Allergic rhinitis

• Recurrent upper respiratory tract infections

• Olfactory (smell) disorders

What Does the Scientific Evidence Say?

Exosome therapies are among the fastest-developing fields of regenerative medicine. Although there is promising research regarding asthma and COPD, exosome and nasal exosome applications are not yet the standard treatment for these diseases. Currently available data need to be supported by broader and long-term clinical trials. Therefore, exosome therapies should only be planned following an expert physician’s evaluation and in accordance with current national regulations. It is crucial that patients do not discontinue their current asthma or COPD treatments without consulting their doctors.

Conclusion

Nasal exosome and general exosome therapies are regenerative medicine approaches that carry the potential to become an important complementary treatment option in the future for chronic respiratory diseases such as asthma and COPD. Although current scientific studies provide positive signals, more clinical evidence is needed regarding the efficacy and safety of these applications.